1. Home
  2. PGR vs SNY Comparison

PGR vs SNY Comparison

Compare PGR & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Progressive Corporation (The)

PGR

Progressive Corporation (The)

N/A

Current Price

$205.09

Market Cap

134.4B

Sector

Finance

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$43.69

Market Cap

116.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PGR
SNY
Founded
1937
1994
Country
United States
France
Employees
N/A
74846
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.4B
116.8B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
PGR
SNY
Price
$205.09
$43.69
Analyst Decision
Buy
Buy
Analyst Count
14
6
Target Price
$242.69
$61.50
AVG Volume (30 Days)
2.6M
4.1M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
6.91%
3.64%
EPS Growth
33.54
N/A
EPS
19.23
N/A
Revenue
$87,671,000,000.00
N/A
Revenue This Year
$3.37
$3.01
Revenue Next Year
$8.05
$5.80
P/E Ratio
$10.47
$6.14
Revenue Growth
16.32
N/A
52 Week Low
$197.92
$43.51
52 Week High
$292.99
$59.17

Technical Indicators

Market Signals
Indicator
PGR
SNY
Relative Strength Index (RSI) 45.05 32.23
Support Level $198.77 N/A
Resistance Level $215.87 $48.97
Average True Range (ATR) 3.94 0.68
MACD -0.43 -0.36
Stochastic Oscillator 30.83 6.20

Price Performance

Historical Comparison
PGR
SNY

About PGR Progressive Corporation (The)

Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 24 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: